Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.4 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.4 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | | | |
| Research and development | 326.9 | 168.8 | 119.2 | 52.2 |
| General and administrative | 137.0 | 45.6 | 27.4 | 10.3 |
| EBIT | -463.6 | -214.4 | -146.6 | -62.5 |
| EBIT margin | -126659.3% | | | |
| Pre-tax income | -451.8 | -211.9 | -138.7 | -60.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -453.7 | -274.6 | -200.9 | -73.0 |
| Net margin | -123973.5% | | | |
| |
| Diluted EPS | ($1.38) | ($2.77) | ($2.03) | ($0.73) |
| Shares outstanding (diluted) | 328.9 | 99.0 | 99.1 | 100.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|